SIRIPIPATTANAMONGKOL, C.; SRINARONG, C.; ASA, P. Effectiveness and safety of Pegylated-Interferon/Ribavirin and direct acting antiretroviral: DAA treatment in chronic hepatitis C in Chiangrai Prachanukroh hospital. เชียงรายเวชสาร, Chiang Rai, Thailand, v. 11, n. 1, p. 41–54, 2019. Disponível em: https://he01.tci-thaijo.org/index.php/crmjournal/article/view/185641. Acesso em: 2 ต.ค. 2026.